Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.550
0.00 (0.00%)
Aug 6, 2026, 4:00 PM CET
Pangaea Oncology Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 14.52 | 14.27 | 7.39 | 4.37 | 4.6 | |
Revenue Growth | 1.78% | 93.14% | 69.16% | -5.11% | 12.29% |
Cost of Revenue | 2.31 | 2.5 | 1.88 | 2.56 | 1.54 |
Gross Profit | 12.21 | 11.77 | 5.51 | 1.8 | 3.07 |
Selling, General & Admin | 10.15 | 9.42 | 5.41 | 3.59 | 3.16 |
Depreciation & Amortization Expenses | 2.78 | 2.56 | 1.7 | 1.24 | 0.99 |
Other Operating Expenses | 3.02 | 1.86 | 1.18 | -0.46 | -0.55 |
Total Operating Expenses | 15.94 | 13.83 | 8.28 | 4.36 | 3.6 |
Operating Income | -3.73 | -2.06 | -2.78 | -2.56 | -0.53 |
Interest Income | 0 | 0.02 | 0.12 | 0.02 | 0 |
Interest Expense | -0.3 | -0.3 | -0.13 | -0.19 | -0.27 |
Other Non-Operating Income (Expense) | 0.01 | 0.65 | 0.32 | -0.11 | -0.3 |
Total Non-Operating Income (Expense) | -0.29 | 0.36 | 0.32 | -0.28 | -0.57 |
Pretax Income | -4.02 | -1.69 | -2.46 | -2.84 | -1.1 |
Provision for Income Taxes | -0.46 | -0.5 | 1.28 | -0.11 | -0.46 |
Net Income | -3.57 | -1.27 | -4.77 | -2.72 | -0.64 |
Minority Interest in Earnings | 0.03 | -0.1 | -0.27 | -0.01 | - |
Earnings From Discontinued Operations | - | -0.07 | -1.04 | - | - |
Net Income to Common | -3.6 | -1.17 | -4.5 | -2.71 | -0.64 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 36 | 34 | 30 | 30 | 22 |
Shares Outstanding (Diluted) | 36 | 34 | 30 | 30 | 22 |
Shares Change | 5.19% | 13.26% | -0.98% | 35.39% | 20.79% |
EPS (Basic) | -0.10 | -0.03 | -0.15 | -0.09 | -0.03 |
EPS (Diluted) | -0.10 | -0.03 | -0.15 | -0.09 | -0.03 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -2.97 | -5.05 | -2.65 | -3.7 | -2.53 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.08 | -0.15 | -0.09 | -0.12 | -0.11 |
Gross Margin | 84.07% | 82.51% | 74.52% | 41.31% | 66.62% |
Operating Margin | -25.70% | -14.41% | -37.60% | -58.58% | -11.58% |
Profit Margin | -24.57% | -8.88% | -64.62% | -62.37% | -13.94% |
FCF Margin | -20.44% | -35.38% | -35.92% | -84.61% | -54.89% |
EBITDA | -0.95 | 0.52 | -0.96 | -1.32 | 0.46 |
EBITDA Margin | -6.55% | 3.65% | -13.03% | -30.17% | 9.98% |
EBIT | -3.73 | -2.06 | -2.78 | -2.56 | -0.53 |
EBIT Margin | -25.70% | -14.41% | -37.60% | -58.58% | -11.58% |
Effective Tax Rate | 11.35% | 29.27% | -52.08% | 4.04% | 41.56% |